These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Kerkerian L, Salin P, Nieoullon A. Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926 [Abstract] [Full Text] [Related]
6. Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway. Salin P, Kerkerian L, Nieoullon A. Exp Brain Res; 1990 Sep; 81(2):363-71. PubMed ID: 1975787 [Abstract] [Full Text] [Related]
7. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat. Soghomonian JJ, Chesselet MF. Neuroscience; 1991 Sep; 42(1):49-59. PubMed ID: 1677745 [Abstract] [Full Text] [Related]
9. Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals. Warenycia MW, McKenzie GM. J Neural Transm; 1987 Sep; 70(3-4):217-32. PubMed ID: 3119772 [Abstract] [Full Text] [Related]
10. Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence. Kerkerian L, Bosler O, Pelletier G, Nieoullon A. Neurosci Lett; 1986 May 06; 66(1):106-12. PubMed ID: 2872630 [Abstract] [Full Text] [Related]
11. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density. Masuo Y, Pélaprat D, Montagne MN, Scherman D, Rostène W. Brain Res; 1990 Mar 05; 510(2):203-10. PubMed ID: 1970504 [Abstract] [Full Text] [Related]
13. Influence of prelimbic and sensorimotor cortices on striatal neurons in the rat: electrophysiological evidence for converging inputs and the effects of 6-OHDA-induced degeneration of the substantia nigra. Florio T, Di Loreto S, Cerrito F, Scarnati E. Brain Res; 1993 Aug 13; 619(1-2):180-8. PubMed ID: 8374776 [Abstract] [Full Text] [Related]
14. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat. Paturle L, Fage D, Fourrier O, Vernier P, Feuerstein C, Demenge P, Scatton B. Brain Res; 1987 Feb 03; 402(2):383-6. PubMed ID: 3828803 [Abstract] [Full Text] [Related]
15. Intrastriatal transplants of embryonic dopaminergic neurons counteract the increase of striatal enkephalin immunostaining but not serotoninergic sprouting elicited by a neonatal lesion of the nigrostriatal dopaminergic pathway. Abrous DN, Manier M, Mennicken F, Feuerstein C, Le Moal M, Herman JP. Eur J Neurosci; 1993 Feb 01; 5(2):128-36. PubMed ID: 7903185 [Abstract] [Full Text] [Related]
16. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway. Ariano MA. Brain Res; 1988 Mar 08; 443(1-2):204-14. PubMed ID: 2965958 [Abstract] [Full Text] [Related]
17. gamma-Aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two modes of regulation? Samuel D, Kumar U, Nieoullon A. J Neurochem; 1988 Dec 08; 51(6):1704-10. PubMed ID: 3141584 [Abstract] [Full Text] [Related]
18. Ultrastructural features of the choline acetyltransferase-containing neurons and relationships with nigral dopaminergic and cortical afferent pathways in the rat striatum. Dimova R, Vuillet J, Nieoullon A, Kerkerian-Le Goff L. Neuroscience; 1993 Apr 08; 53(4):1059-71. PubMed ID: 7685068 [Abstract] [Full Text] [Related]